EMEA

Novo Nordisk weight-loss blow is warning for Lilly

20 Dec 2024

Shares of the $368 bln Ozempic maker fell up to 27% after trials of a critical medication disappointed. That will make it easier for upstarts like AstraZeneca to muscle into an increasingly competitive obesity market. It’s potentially bad news for market leader Eli Lilly too.

European software deal runs on servers of hope

19 Dec 2024

Microsoft supplier SoftwareOne is paying a mere 13% premium to buy Norway’s Crayon Group for $1.4 bln, mostly in shares. Private equity could swoop for the enlarged entity, improving the picture for the target’s investors. Right now, they’re obliged to rely too much on hope.

Adland’s main post-M&A tussle is for second place

19 Dec 2024

Omnicom and IPG are creating the world’s largest agency, but Publicis’ superior growth profile should keep it in pole position. UK group WPP risks winding up in third place. Yet that hinges on whether advertising’s big merger fast-tracks AI investment, or impedes it.

Ailing UK water sector gets a risky lifeline

19 Dec 2024

Ofwat will allow companies to raise prices and make higher returns. Britain’s water regulator is rightly helping groups fund 104 bln pounds of needed investment. But given one key beneficiary is shaky Thames Water, public patience with the sector may decline further.

Brick phones will ring in an unlikely revival

19 Dec 2024

Nokia handsets of the early 2000s are appealing to a generation seeking a digital detox. The market, which is only 2% of US devices, is growing fast having doubled in a year. With the likes of Australia banning social media for under-16s, Apple and Samsung may pivot or lose out.

Luxury firms will warily cut prices to boost sales

19 Dec 2024

High-end goods cost 54% more than before Covid. Yet the likes of LVMH refuse to blame lower volumes on more expensive wares. The fact is that rich Chinese consumers care more about savings than status symbols. Sacrificing margins will be an uncomfortable but inevitable strategy.

Hot topics of 2024 will smoulder into new year

19 Dec 2024

Inflation in the United States, a struggling Chinese economy and Boeing’s existential challenges were among the stories that dominated this year. In this Viewsroom podcast, Breakingviews columnists explain why these issues – among others – will keep cropping up in 2025.

Saudi’s sports M&A splurge will get smarter

18 Dec 2024

The kingdom has so far focused on mature markets like golf and men’s soccer, including spending $400 mln on English team Newcastle. Rugby and women’s soccer arguably have greater growth potential. Saudi will make the switch in 2025 and provide some much-needed investment.

EU joint debt will reappear despite French squalls

18 Dec 2024

Covid-19 saw the European Union ditch its qualms about issuing bonds backed by the 27-state bloc. Ukraine could spur a similar leap forward. France’s political turmoil is a problem, but Russian aggression and US inaction could force member states to club together to fund defence.

Watchdogs finally detect scent of hedge-fund risk

18 Dec 2024

The Financial Stability Board proposed ideas including leverage caps that may affect Ken Griffin’s Citadel and Israel Englander’s Millennium. The new US administration will balk. Yet with hedge fund borrowing surging to $5 trln, it’s worth fleshing out rules ahead of any blowup.

Labour and labour market point to slower BoE cuts

18 Dec 2024

The Bank of England is set to leave rates on hold this week. The economy is weak but pay growth is strong, keeping inflation above 2%. The government’s plans will boost GDP and prices in 2025. Until unemployment rises, Governor Andrew Bailey cannot ease as fast as foreign peers.

Vivendi’s discount haunts Bollorés post-breakup

17 Dec 2024

The media group split in four to shed a conglomerate valuation penalty. The bits are now collectively worth just 8 bln euros, implying no upside from the move. One lesson is that the discount was always down to the controlling Bolloré clan’s influence rather than the structure.

Green energy will be a smart contrarian trade

17 Dec 2024

Donald Trump’s dislike of offshore wind and threats to axe subsidies imply the renewable sector is one to swerve in 2025. Yet the US president-elect is primarily focused on keeping energy costs low. If permitting gets sped up, Big Tech-driven demand could help green power too.

BHP will try a club deal for Anglo American

17 Dec 2024

The Aussie miner is now free to make another takeover proposal for its smaller rival, whose copper assets still appeal to CEO Mike Henry. But paying a big premium looks harder to justify second time round. Partnering with a rival like Glencore or Vale may smooth the way.

Obesity giants will begin $80 bln M&A face-off

17 Dec 2024

Eli Lilly and Novo Nordisk will need to invest the war chests they are amassing from sales of weight-loss drugs. They could snap up rivals like Zealand Pharma, or forge into new areas, say by buying autoimmune player Argenx. Pressure to do deals raises the risk of overpaying.

Oil will aid rather than hinder Trump-MbS bromance

16 Dec 2024

Both the US president-elect and the Saudi crown prince want to pump more crude in 2025. Yet US drillers aren’t certain to do so. And Mohammed bin Salman may be able to extract a quid pro quo in return for deploying spare oil capacity should Donald Trump crack down on Iran.

AstraZeneca lacks good medicine for Chinese limbo

13 Dec 2024

Executives at the $205 bln drugmaker have been detained by Beijing, hitting its shares. One way for CEO Pascal Soriot to ringfence China risk from the rest of AstraZeneca might be to list or spin off the unit. Yet that might just highlight fresh reasons to mark down the stock.

Delivery Hero investors’ meal is stuck in traffic

13 Dec 2024

Shares in the $9.5 bln online takeaway group have dipped since it sold a $2 bln stake in its Middle East unit through a Dubai IPO. CEO Niklas Östberg can now cut net debt, but many of his businesses still burn cash. A more comprehensive breakup may be the best option on the menu.

India tightens its crude bear hug of Russia

12 Dec 2024

Reliance is set to buy Rosneft oil worth $13 bln a year for a decade in the biggest energy deal between the countries. It helps New Delhi cut its current account gap and buy goodwill ahead of Vladimir Putin’s visit. But Moscow’s struggle to manage a flood of rupees may intensify.

Berlin can curb but not stop a Romania-TikTok mess

12 Dec 2024

The app is under scrutiny for enabling meddling in Bucharest’s elections. Given a blanket TikTok ban is beyond the EU’s remit, Germany’s February poll may go the same way. Yet Berlin could also coordinate better with tech platforms ahead of time – which Romania didn’t.